Valitor is conquering limitations of established drug targets by leveraging its multivalent biopolymer technology to maximize benefits for patients
Valitor is conquering limitations of established drug targets by leveraging its multivalent biopolymer technology to maximize benefits for patients. The company is initially focused on developing long-acting molecules aimed at capturing several large markets in ophthalmology.